PL1716169T3 - Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotracheale - Google Patents
Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotrachealeInfo
- Publication number
- PL1716169T3 PL1716169T3 PL05701653T PL05701653T PL1716169T3 PL 1716169 T3 PL1716169 T3 PL 1716169T3 PL 05701653 T PL05701653 T PL 05701653T PL 05701653 T PL05701653 T PL 05701653T PL 1716169 T3 PL1716169 T3 PL 1716169T3
- Authority
- PL
- Poland
- Prior art keywords
- proteins
- vaccines
- ornithobacterium rhinotracheale
- nucleic acids
- subunit vaccines
- Prior art date
Links
- 241001135620 Ornithobacterium rhinotracheale Species 0.000 title abstract 3
- 229940031626 subunit vaccine Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 229960005486 vaccine Drugs 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 108020004414 DNA Proteins 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04075427 | 2004-02-11 | ||
| EP05701653A EP1716169B1 (en) | 2004-02-11 | 2005-02-09 | Ornithobacterium rhinotracheale subunit vaccines |
| PCT/EP2005/050577 WO2005077972A1 (en) | 2004-02-11 | 2005-02-09 | Ornithobacterium rhinotracheale subunit vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1716169T3 true PL1716169T3 (pl) | 2010-05-31 |
Family
ID=34854650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05701653T PL1716169T3 (pl) | 2004-02-11 | 2005-02-09 | Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotracheale |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080008718A1 (pl) |
| EP (1) | EP1716169B1 (pl) |
| JP (1) | JP2007537723A (pl) |
| AT (1) | ATE450546T1 (pl) |
| AU (1) | AU2005212850B2 (pl) |
| BR (1) | BRPI0507281A (pl) |
| CA (1) | CA2553703A1 (pl) |
| DE (1) | DE602005018021D1 (pl) |
| ES (1) | ES2336684T3 (pl) |
| MX (1) | MXPA06008760A (pl) |
| PL (1) | PL1716169T3 (pl) |
| WO (1) | WO2005077972A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10399019I2 (de) * | 1992-10-14 | 2005-07-21 | Akzo Nobel Nv | Gefl}gelkrankheit verursachende neue Bakterie und daraus stammender Impfstoff. |
| US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
-
2005
- 2005-02-09 MX MXPA06008760A patent/MXPA06008760A/es active IP Right Grant
- 2005-02-09 PL PL05701653T patent/PL1716169T3/pl unknown
- 2005-02-09 EP EP05701653A patent/EP1716169B1/en not_active Not-in-force
- 2005-02-09 JP JP2006552621A patent/JP2007537723A/ja active Pending
- 2005-02-09 ES ES05701653T patent/ES2336684T3/es active Active
- 2005-02-09 DE DE602005018021T patent/DE602005018021D1/de active Active
- 2005-02-09 WO PCT/EP2005/050577 patent/WO2005077972A1/en not_active Application Discontinuation
- 2005-02-09 BR BRPI0507281-6A patent/BRPI0507281A/pt not_active IP Right Cessation
- 2005-02-09 US US10/588,992 patent/US20080008718A1/en not_active Abandoned
- 2005-02-09 CA CA002553703A patent/CA2553703A1/en not_active Abandoned
- 2005-02-09 AT AT05701653T patent/ATE450546T1/de not_active IP Right Cessation
- 2005-02-09 AU AU2005212850A patent/AU2005212850B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06008760A (es) | 2007-01-23 |
| JP2007537723A (ja) | 2007-12-27 |
| DE602005018021D1 (de) | 2010-01-14 |
| US20080008718A1 (en) | 2008-01-10 |
| AU2005212850A1 (en) | 2005-08-25 |
| EP1716169A1 (en) | 2006-11-02 |
| ES2336684T3 (es) | 2010-04-15 |
| BRPI0507281A (pt) | 2007-07-03 |
| WO2005077972A1 (en) | 2005-08-25 |
| AU2005212850B2 (en) | 2009-11-26 |
| CA2553703A1 (en) | 2005-08-25 |
| EP1716169B1 (en) | 2009-12-02 |
| ATE450546T1 (de) | 2009-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010138263A3 (en) | Novel aav 's and uses thereof | |
| UA100682C2 (ru) | АНТИТЕЛО, КОТОРОЕ НЕЙТРАЛИЗУЕТ ЧЕЛОВЕЧЕСКИЙ ЦИТОМЕГАЛОВИРУС (hCMV), И ЕГО ПРИМЕНЕНИЕ | |
| NZ591415A (en) | Haemophilus influenzae type B | |
| WO2007104529A3 (en) | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
| WO2006119987A3 (en) | Recombinant n-glycosylated proteins from procaryotic cells | |
| EP2037737A4 (en) | PROTEINS, NUCLEIC ACIDS FOR THEIR CODING AND CORRESPONDING USES. | |
| WO2008077945A3 (en) | Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies | |
| MX2010005783A (es) | Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas. | |
| SG162834A1 (en) | Refolding of recombinant proteins | |
| IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
| WO2005118813A3 (en) | Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein | |
| MXPA06008217A (es) | Vacunas con subunidad de lawsonia intracellularis. | |
| WO2007042289A3 (en) | Nanobodies™ and polypeptides against egfr and igf-ir | |
| WO2009124312A3 (en) | Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same | |
| WO2006120230A3 (en) | Host cell specific binding molecules capable of neutralizing viruses and uses thereof | |
| WO2007050095A3 (en) | Improved vaccines and methods for using the same | |
| WO2004031210A3 (en) | Optimized multi-epitope constructs and uses thereof | |
| WO2007045019A3 (en) | Polyoleosins | |
| WO2005033265A3 (en) | Optimized multi-epitope constructs and uses thereof | |
| DK1664100T3 (da) | Vaccine med underenhed af Lawsonia intracellularis | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| TW200801034A (en) | Novel sea lice vaccine | |
| PL1716169T3 (pl) | Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotracheale | |
| WO2009083968A8 (en) | Novel protein | |
| WO2004024769A3 (en) | Ostertagia vaccine |